Adjuvant therapy in the treatment of stage II uterine carcinoma

被引：1
|
作者：
Berry, L. K. [1 ]
Harbin, L. M. [1 ]
Buchanan, T. R. [2 ]
Kohler, M. F. [1 ]
Cooper, L. [1 ]
Creasman, W. T. [1 ]
Graybill, W. A. [1 ]
机构：
[1] Med Univ South Carolina, Charleston, SC 29425 USA
[2] Washington Univ, Sch Med St Louis, St Louis, MO USA
来源：
GYNECOLOGIC ONCOLOGY | 2018年 / 149卷 / 03期
关键词：
D O I：
10.1016/j.ygyno.2018.03.019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10
引用
收藏
页码：623 / 624
页数：2
相关论文
共 50 条
  • [41] National patterns of adjuvant treatment for stage I uterine serous carcinoma: A SEER-Medicare analysis
    Haggerty, A. F.
    Mastroyannis, S. A.
    Graul, A.
    Brensinger, C. M.
    Giuntoli, R. L., II
    Latif, N. A.
    Ko, E. M.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 155 - 156
  • [42] Limiting adjuvant chemotherapy in stage IA uterine papillary serous carcinoma
    Goodwin, Halle
    Mujumdar, Vaidehi
    Chen, Jane
    Brown, Jubilee
    Crane, Erin
    Lees, Brittany
    Puechl, Allison
    Casablanca, Yovanni
    Naumann, R. Wendel
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S431 - S431
  • [43] Is adjuvant treatment in early-stage uterine sarcomas beneficial?
    Sepulveda-Rivera, C. M.
    Barquet-Munoz, S. A.
    Perez-Plascencia, C.
    Salcedo-Hernandez, R.
    Ruiz-Beltran, A. M.
    Cantu de Leon, D.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2018, 39 (03) : 443 - 447
  • [44] Is adjuvant therapy necessary for Stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging?
    Kwon, J. S.
    Abrams, J.
    Sugimoto, A.
    Carey, M. S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (04) : 820 - 824
  • [45] ADJUVANT EXTERNAL BEAM THERAPY FOR PATHOLOGICAL STAGE-I AND OCCULT STAGE-II ENDOMETRIAL CARCINOMA
    STRYKER, JA
    PODCZASKI, E
    KAMINSKI, P
    VELKLEY, DE
    CANCER, 1991, 67 (11) : 2872 - 2879
  • [46] ADJUVANT CHEMOIMMUNOTHERAPY IN STAGE-II CARCINOMA OF THE BREAST
    GIULIANO, AE
    SPARKS, FC
    PATTERSON, K
    SPEARS, I
    MORTON, DL
    JOURNAL OF SURGICAL ONCOLOGY, 1986, 31 (04) : 255 - 259
  • [47] Early-stage Uterine Pure and Mixed Clear Cell Carcinoma: Outcomes and Recurrence With and Without Adjuvant Therapy
    Chang-Halpenny, Christine N.
    Natarajan, Sathima
    Hwang-Graziano, Julie M.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (04): : 371 - 378
  • [48] Impact of Adjuvant Pelvic Radiation Therapy in Stage I Uterine Sarcoma
    Magnuson, W. J.
    Petereit, D. G.
    Anderson, B. M.
    Geye, H. M.
    Bradley, K. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S419 - S420
  • [49] The role of adjuvant therapy in early stage high grade uterine leiomyosarcoma
    Klobocista, M.
    Schwartz, M. A.
    Van Arsdale, A.
    Yessaian, A. A.
    Sposto, R.
    Muderspach, L. I.
    Roman, L.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 169 - 170
  • [50] Variation in adjuvant therapy for stage II serous uterine cancer in the United States and its impact on survival outcome
    Graul, A.
    Haggerty, A. F.
    Brensinger, C. M.
    Lin, L. L.
    Giuntoli, R. L., II
    Latif, N. A.
    Kim, S. H.
    Burger, R. A.
    Morgan, M. A.
    Ko, E. M.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 202 - 202
12345